C12Y 304/21004
Trypsin
Official title: Trypsin (3.4.21.4)
C12Y304/21004 (Trypsin) appears on 170 US grants and 280 published applications in this corpus.
Search patents in C12Y- Granted patents
- 170
- Published applications
- 280
- Assignees
- 137
- Inventors
- 514
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 6 |
| 2005 | 0 | 1 |
| 2006 | 3 | 2 |
| 2007 | 0 | 3 |
| 2008 | 3 | 6 |
| 2009 | 0 | 7 |
| 2010 | 0 | 4 |
| 2011 | 3 | 3 |
| 2012 | 4 | 8 |
| 2013 | 3 | 3 |
| 2014 | 5 | 6 |
| 2015 | 9 | 14 |
| 2016 | 10 | 16 |
| 2017 | 7 | 21 |
| 2018 | 7 | 17 |
| 2019 | 5 | 22 |
| 2020 | 11 | 16 |
| 2021 | 19 | 25 |
| 2022 | 18 | 34 |
| 2023 | 13 | 23 |
| 2024 | 18 | 18 |
| 2025 | 12 | 13 |
| 2026 | 5 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for analyzing protein29 Sep 2026US 12,747,465 B2Hitachi, Ltd.
- Acellular dermal matrix for skin and surgical reconstruction and methods of making same28 Jul 2026US 12,691,202 B1Humabiologics, Inc.
- Materials and methods for isolating self-antigen polypeptides31 Mar 2026US 12,590,120 B2Impact Proteomics
- Method for extracting unfractionated heparin from camel intestinal mucosa3 Mar 2026US 12,565,541 B1Camelx Biomedical & Research
- Methods of isolating cells from placental tissue3 Feb 2026US 12,540,309 B2Meharry Medical College
- Antimicrobial defensin peptide folding variants1 Oct 2026US 2026/0297145 A1Donald Danforth Plant Science Center
- Reactive and sorbent materials20 Aug 2026US 2026/0240896 A1Guild Associates, Inc.
- Pharmaceutical composition for treating and/or preventing cancer20 Aug 2026US 2026/0240962 A1Toray Industries, Inc.
- Linker sequence potency assays for multiple coding nucleic acids13 Aug 2026US 2026/0234696 A1BioNTech SE
- Method of obtaining recombinant human brain-derived neurotrophic factor6 Aug 2026US 2026/0226122 A1Dompé Farmaceutici S.P.A.
Most cited
By later US patents
- Modifying enzymes with polyethylene glycol and product produced thereby253US 4,002,531 APierce Chemical Company · 1977
- Reduced-pressure treatment systems and methods employing debridement mechanisms75US 8,486,032 B2KCI Licensing, Inc. · 2013
- Proteolytic enzymes as adjuncts to antibiotic prophylaxis of contaminated wounds71US 3,940,478 ASutures, Inc. · 1976
- Methods for treating pervasive development disorders63US 6,632,429 B12003
- Method for treating pervasive development disorders63US 8,105,584 B2Curemark, LLC · 2012